Statistics on Biotechnology Use Results by sector of operation Company sector. Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production Unidades: specified in variables Total Main Secondary dwellings Tool Companies that carry out R&D in Biotechnology 1.056 551 183 323 %Companies according to biotechnology used: Genetic code 36 46 22 26 %Companies according to biotechnology used: Functional units 45 51 38 38 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 27 33 21 21 %Companies according to biotechnology used: Bioprocesses 47 41 48 55 %Companies according to biotechnology used: Sub-cellular organisms 8 12 8 4 %Companies according to biotechnology used: Bio-computing 25 33 13 17 %Companies according to biotechnology used: Nanobiotechnology 13 18 12 5 %Companies according to biotechnology used: Other 15 16 16 13 %Company by field(s) of ultimate application of biotechnology use: Human Health 49 65 38 27 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 20 25 19 13 %Company by field(s) of ultimate application of biotechnology use: Food products 30 23 31 42 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 23 20 24 26 %Company by field(s) of ultimate application of biotechnology use: Environment 13 11 25 11 %Company by field(s) of ultimate application of biotechnology use: Industry 12 13 19 7 Personnel in R&D in biotechnology (no. of persons) 10.719 5.901 1.572 3.245 Personnel in R&D in biotechnology (no. of persons): Researchers 6.131 3.640 912 1.579 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.588 2.261 661 1.667 Personnel in R&D in biotechnology (no. of persons): women 6.040 3.443 844 1.753 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 3.411 2.087 511 812 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.629 1.356 333 941 Personnel in R&D in biotechnology (FTE) 7.751 4.659,2 980,5 2.111,1 Personnel in R&D in biotechnology (FTE): Researchers 4.518,1 2.855,6 621 1.041,5 Personnel in R&D in biotechnology (FTE): Technicians and assistants 3.232,7 1.803,6 359,5 1.069,6 Personnel in R&D in biotechnology (FTE): women 4.471,4 2.697,8 549,7 1.223,9 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.562,7 1.637,8 360,6 564,3 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.908,7 1.060 189,1 659,6 Internal expenditure on R&D (thousands of euros) 679.558 446.123 82.011 151.424 1) By nature of the expense: Current expenses 634.631 412.211 78.386 144.035 1.1) Remuneration to researchers 228.857 153.206 31.881 43.769 1.2) Remuneration to technicians and assistants 104.498 61.567 12.726 30.205 1.3) Other current expenses 301.276 197.437 33.779 70.060 2) By nature of the expense: Capital expenses 44.927 33.912 3.625 7.389 2.1) Land and buildings 2.585 2.159 90 337 2.2) Equipment and instruments 23.569 14.228 3.239 6.101 2.3) Acquisition of specific R+D software 1.392 709 128 555 2.4) Otros productos de propiedad intelectual específicos para I+D 17.381 16.817 168 396 1) By origin of the funds: National funds 556.297 336.896 71.496 147.904 1.1) Own funds 387.010 240.941 42.317 103.752 1.2) From companies 86.025 41.093 17.175 27.757 1.3) Public Administration funds 74.764 49.704 11.115 13.944 1.4) From Universities 408 340 2 66 1.5) From non profit private institutions 8.090 4.818 887 2.385 1) By origin of the funds: Foreign funds 123.262 109.227 10.514 3.520 2.1) From EU programmes 25.125 14.287 7.967 2.871 2.2) Other foreign funds 98.137 94.940 2.547 649 Purchase of R&D services in biotechnology (thousands of euros) 147.558 104.940 19.473 23.146 Purchase of R&D services in biotechnology (thousands of euros): In Spain 76.875 54.648 12.216 10.011 Purchase of R&D services in biotechnology (thousands of euros): Abroad 70.683 50.292 7.256 13.135 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 49 59 45 32 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 14 11 20 15 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 16 13 25 17 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 13 12 21 10 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets 18 20 24 12 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels 18 21 19 11 %Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception 17 16 21 16 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 40 39 33 %Companies that consider the following obstacles as very important considering biotechnology development : Time / cost 51 56 52 44 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 18 17 22 18 % Companies that have requested biotechnology patents 16 23 9 6 Number of patents requested 746 539 142 65 % Companies with income of an international origin related to biotechnological activities 23,3 33,8 11,6 12 % Turnover representing income of an international origin related to biotechnological activities 1,2 14,5 0 0,7 % Income of of an international origin related to biotechnological activities distributed in: Income received from the EU 60,4 66,6 74,8 24,7 % Income of of an international origin related to biotechnological activities distributed in: Income received from other countries 39,6 33,4 25,3 75,3 % Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services 80,9 78 70,6 98,2 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 17,8 21,3 0,3 1,3 % Income of an international origin related with activities according to the classification: Operating source abroad 1,3 0,6 29 0,6 % Income of an international origin related with activities according to the classification: Other 0,1 0,1 0 0 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute